Oertel Michael, Menthena Anuradha, Dabeva Mariana D, Shafritz David A
Marion Bessin Liver Research Center, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, USA.
Gastroenterology. 2006 Feb;130(2):507-20; quiz 590. doi: 10.1053/j.gastro.2005.10.049.
BACKGROUND & AIMS: A critical property of stem cells is their ability to repopulate an organ or tissue under nonselective conditions. The aims of this study were to determine whether we could obtain reproducible, high levels of liver repopulation by transplanted fetal liver stem/progenitor cells in normal adult liver and the mechanism by which liver replacement occurred.
Wild-type (dipeptidyl peptidase IV [DPPIV(+)]) embryonic day (ED) 14 fetal liver cells underwent transplantation into DPPIV(-) mutant F344 rats to follow the fate and differentiation of transplanted cells. To determine the mechanism for repopulation, proliferation and apoptosis of transplanted and host liver cells were also followed.
Transplanted ED 14 fetal liver cells proliferated continuously for 6 months, differentiated into mature hepatocytes, and replaced 23.5% of total liver mass. The progeny of transplanted cells were morphologically and functionally indistinguishable from host hepatocytes and expressed unique liver-specific genes commensurate with their location in the hepatic lobule. Repopulation was based on greater proliferative activity of transplanted cells and reduced apoptosis of their progeny compared with host hepatocytes, coupled with increased apoptosis of host hepatocytes immediately adjacent to transplanted cells. This process, referred to as cell-cell competition, has been described previously in Drosophila during wing development.
We show for the first time that cell-cell competition, a developmental paradigm, can be used to replace functional organ tissue in an adult mammalian species under nonselective conditions and may serve as a strategy for tissue reconstitution in a wide variety of metabolic and other disorders involving the liver, as well as other organs.
干细胞的一个关键特性是它们在非选择性条件下重新填充器官或组织的能力。本研究的目的是确定我们是否能够通过将胎肝干细胞/祖细胞移植到正常成年肝脏中获得可重复的、高水平的肝脏再填充,以及肝脏替代发生的机制。
将野生型(二肽基肽酶IV [DPPIV(+)])胚胎第14天(ED14)的胎肝细胞移植到DPPIV(-)突变的F344大鼠中,以追踪移植细胞的命运和分化。为了确定再填充的机制,还追踪了移植和宿主肝细胞的增殖和凋亡情况。
移植的ED14胎肝细胞持续增殖6个月,分化为成熟肝细胞,并替代了23.5%的肝脏总质量。移植细胞的后代在形态和功能上与宿主肝细胞无法区分,并表达了与其在肝小叶中的位置相称的独特肝脏特异性基因。与宿主肝细胞相比,再填充是基于移植细胞更高的增殖活性以及其后代更低的凋亡率,同时移植细胞紧邻区域的宿主肝细胞凋亡增加。这个过程,称为细胞-细胞竞争,先前在果蝇翅膀发育过程中已有描述。
我们首次表明,细胞-细胞竞争这一发育模式可用于在非选择性条件下替代成年哺乳动物物种中的功能性器官组织,并且可能作为一种策略用于多种涉及肝脏以及其他器官的代谢和其他疾病中的组织重建。